When was Teva Pharmaceuticals founded?

Teva Pharmaceuticals was founded in 1901 and raised its 1st funding round 108 years after it was founded.

Where is Teva Pharmaceuticals located?

Teva Pharmaceuticals is headquartered in Petah Tikva, Israel.

How many employees does Teva Pharmaceuticals have?

As of Sep 30, 2026, the latest employee count at Teva Pharmaceuticals is 30269.

Is Teva Pharmaceuticals a funded company?

Teva Pharmaceuticals is a funded company, having raised a total of $500M across 3 funding rounds to date. The company's 1st funding round was a $***** PE round, raised on Dec 02, 2009.

When was the latest funding round of Teva Pharmaceuticals?

Teva Pharmaceuticals' latest funding was a $***** Conventional Debt round on Apr 10, 2019, with participation from 0 investor.

Where does Teva Pharmaceuticals rank among its competitors?

Teva Pharmaceuticals ranks 2nd amongst 1239 active competitors, of which 43 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Laboratorio Reig Jofre, which secured $14.7M in May, 2025.

Who are the top competitors of Teva Pharmaceuticals?

Teva Pharmaceuticals' top competitors include Bayer, Wockhardt and Biological E. Among them, Laboratorio Reig Jofre secured the most recent funding round in May, 2025.

Teva Pharmaceuticals - 2026 Company Profile, Team, Funding & Competitors

Teva Pharmaceuticals is a public company based in Petah Tikva (Israel), founded in 1901 by Gunther Friedlander, Aviv Sadka, Yitschak Elstein, Moshe Levin and Chaim Salomon. It operates as a Traditional company engaged in manufacturing generics. Teva Pharmaceuticals has raised $500M in funding. The company has 1239 active competitors, including 43 funded and 337 that have exited. Its top competitors include companies like Bayer, Wockhardt and Biological E.

Company Details

In 2023, the company recorded annual revenues of $14.94B and a net loss of $2.35B

Website: www.tevapharm.com/
Social
Email ID: *****@tevapharm.com

Key Metrics

Founded Year

1901

Location

Petah Tikva, Israel

Stage

Public

Total Funding

$500M in 3 rounds

Latest Funding Round

Conventional Debt, Apr 10, 2019, $*****

Investors

Berkshire Hathaway & 4 more

Ranked

2^nd among 1239 active competitors

Employee Count

30,269 as on Sep 30, 2026

Investment & Acquisitions

Emalex Biosciences & 39 more

Similar Companies

The Alvogen & 1463 more

Exit Details

Public

View Teva Pharmaceuticals' full profile

Teva Pharmaceuticals is associated with 6 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
TIVA s.r.o. CIN: 60747323 , Czech Republic, Active	May 05, 1995	-	-
Favea Pharmaceutical Technologies, s.r.o. CIN: 26834367 , Czech Republic, Active	May 10, 2004	-	-
MGin Holding s.r.o. CIN: 19269871 , Czech Republic, Active	Apr 20, 2023	-	-
CEQ Czech, s.r.o. CIN: 06024289 , Czech Republic, Active	Apr 20, 2017	-	-
Teva Pharmaceutical Industries Ltd CIN: 520013954 , Israel, Active	Feb 12, 1944	-	-	-
TEVA PHARMACEUTICAL AND CHEMICAL INDUSTRIES INDIA PRIVATE LIMITED CIN: U24230MH2003FTC326703 , India, Active	May 02, 2003	₹100 - ₹500 Cr (As on Mar 31, 2025)	-

Teva Pharmaceuticals got listed on Dec 20, 1985.

Click here to take a look at Teva Pharmaceuticals's IPO in detail

Teva Pharmaceuticals has raised a total funding of $500M over 3 rounds. Its first funding round was on Dec 02, 2009. Teva Pharmaceuticals has 5 institutional investors.

Here is the list of recent funding rounds of Teva Pharmaceuticals:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 10, 2019	4611216	Conventional Debt	6929976	4647767	7082800	3813812
Mar 01, 2018	6539173	Grant (prize money)	9892185	4153099	9236385	Europa
Dec 02, 2009	3473797	PE	1251221	4093996	9447528	2659149

Access funding benchmarks and valuations. Sign up today!

View details of Teva Pharmaceuticals's funding rounds and investors

The founders of Teva Pharmaceuticals are Gunther Friedlander, Aviv Sadka, Yitschak Elstein, Moshe Levin and Chaim Salomon. Richard Francis is the CEO of Teva Pharmaceuticals.

Here are the details of Teva Pharmaceuticals' key team members:

Gunther Friedlander: Former Co-Founder of Teva Pharmaceuticals and founder of 1 other company.
Aviv Sadka: Business Owner - Global Supply Chain BI of Teva Pharmaceuticals.
Contact Info: 1 email address
Yitschak Elstein: Former Co-Founder of Teva Pharmaceuticals and founder of 1 other company.
Moshe Levin: Former Co-Founder of Teva Pharmaceuticals and founder of 1 other company.
Chaim Salomon: Former Co-Founder of Teva Pharmaceuticals and founder of 1 other company.
Contact Info: 1 email address

View details of Teva Pharmaceuticals's Founder profiles and Board Members

Teva Pharmaceuticals' employee count trend

Teva Pharmaceuticals has 30,269 employees as of Sep 26. Here is Teva Pharmaceuticals's employee count trend over the years:

Employee count trend for Teva Pharmaceuticals

Uncover Teva Pharmaceuticals' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Teva Pharmaceuticals include Bayer, Wockhardt and Biological E. Here is the list of Top 10 competitors of Teva Pharmaceuticals, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Bayer 1863, Leverkusen (Germany), Public	Manufacturer of drugs	-	Digital Pharma Lab, B Capital Fund & 9 others	76/100
2nd	Teva Pharmaceuticals 1901, Petah Tikva (Israel), Public	Traditional company engaged in manufacturing generics	$500M	Berkshire Hathaway, JANA Partners & 3 others	75/100
3rd	Wockhardt 1967, Mumbai (India), Public	Manufacturer of pharmaceuticals, biotechnology products, and active pharmaceutical ingredients	-	HDFC Mutual Fund, Tata Mutual Fund & 12 others	71/100
4th	Biological E 1953, Hyderabad (India), Funding Raised	Developer of vaccines for treating multiple diseases	-	Gates, IFC & 3 others	69/100
5th	Cipla 1935, Mumbai (India), Public	Manufacturer of APIs, generic drugs, and formulation development services	-	MUFG, Eight Roads Ventures & 3 others	69/100
6th	The Alvogen 2009, Morristown (United States), Acquired	Developer and marketer of pharmaceutical products	$156M	Morgan Stanley, IMM Private Equity & 11 others	69/100
7th	Emcure 1981, Pune (India), Public	Developer, manufacturer, and markets a broad range of pharmaceutical products	$50M	Blackstone, Bain Capital	68/100
8th	Amneal 2002, Bridgewater (United States), Public	Manufacturer of generics formulations	-	Tarsadia, GE Capital & 2 others	68/100
9th	Laboratorio Reig Jofre 2000, Barcelona (Spain), Public	Manufacturer of pharmaceutical products and food supplements	-	CDTI, Europa	68/100
10th	Strides Pharma Science 1990, Bengaluru (India), Public	Manufacturer of generic pharmaceutical products and various specialty medical formulations	-	InvAscent, Oman India Joint Investment Fund ... & 2 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Teva Pharmaceuticals's competitors? Click here to see the top ones

Teva Pharmaceuticals has made 20 investments in companies including Nonagon and Microchips Biotech. Teva Pharmaceuticals has also acquired 20 companies including Emalex Biosciences and Anda.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 29, 2026	Acquisition	Emalex Biosciences	2018	Northbrook (United States)
Apr 06, 2021	Investments	Nonagon	2016	Ra anana (Israel)
Aug 03, 2016	Acquisition	Anda	1992	Weston (United States)

Want to know more about where corporates are investing? Sign up today!

See all investments and acquisitions by Teva Pharmaceuticals

Media has covered Teva Pharmaceuticals for a total of 91 events in the last 1 year, 45 of them have been about company updates and 4 about partnerships.